<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04558788</url>
  </required_header>
  <id_info>
    <org_study_id>Cellular stress in GVHD</org_study_id>
    <nct_id>NCT04558788</nct_id>
  </id_info>
  <brief_title>Cellular Stress Reactions During Graft-versus-host Disease</brief_title>
  <official_title>Analysis of Cellular Stress Markers in the Intestine of Patients With Graft-versus-host Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Freiburg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Freiburg</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study has the aim to analyze intestinal expression of cellular stress molecules in&#xD;
      patients with intestinal GVHD. Patients with colitis and patients without intestinal&#xD;
      inflammation will serve as controls.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acute graft-versus-host disease (GVHD) is a major cause of morbidity and mortality in&#xD;
      patients undergoing allogeneic hematopoietic cell transplantation (allo-HCT). Acute GVHD&#xD;
      results from a complex multi-step crosstalk between extensive epithelial tissue damage in the&#xD;
      patient and activation of the allo-reactive immune system transferred with the donor graft.&#xD;
      The conditioning treatment prior to allo-HCT creates an inflamed microenvironment with high&#xD;
      concentrations of pathogen-associated and danger-associated molecular patterns (PAMPs and&#xD;
      DAMPs) as well as pro-inflammatory cytokines. This inflammation is perpetuated by activation&#xD;
      of myeloid immune cells and recruitment of allo-reactive T cells to the intestine.&#xD;
      Enterocytes are subjected to cellular stress and undergo apoptosis. As a result, patients can&#xD;
      develop high-voluminous diarrhea, dehydration, intestinal bleeding, hypalbuminemia, and&#xD;
      generalized infections.&#xD;
&#xD;
      In this study, the investigators aim to analyze the expression of molecules related to&#xD;
      different types of cellular stress in the intestine of patients with acute GVHD. The&#xD;
      hypothesis is that some stress-related markers would be upregulated during GVHD. The results&#xD;
      will be valuable to study the role of cellular stress reactions during acute GVHD&#xD;
      pathogenesis or as potential biomarkers for disease activity.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Immunohistochemical staining</measure>
    <time_frame>1 year</time_frame>
    <description>Immunohistochemical staining</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>GVHD,Acute, Cellular Stress</condition>
  <arm_group>
    <arm_group_label>Uninflamed intestine</arm_group_label>
    <description>Patients who underwent diagnostic endoscopy and received a diagnosis of no intestinal inflammation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Colitis</arm_group_label>
    <description>Patients with active colitis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acute GVHD</arm_group_label>
    <description>Patients with acute gastrointestinal (GI) GVHD</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Immunohistochemistry on intestinal biopsies</intervention_name>
    <description>Immunohistochemistry will be performed on human intestinal biopsies</description>
    <arm_group_label>Acute GVHD</arm_group_label>
    <arm_group_label>Colitis</arm_group_label>
    <arm_group_label>Uninflamed intestine</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        This study will recruit adults at least 18 years of age, who underwent intestinal biopsy&#xD;
        and either had (i) non-inflamed intestinal tissue, (ii) colitis, (iii) graft-versus-host&#xD;
        disease.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Age &gt;18 years intestinal biopsy depending on cohort: healthy intestinal tissue, colitis or&#xD;
        GVHD&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Robert Zeiser, MD</last_name>
    <phone>076127034010</phone>
    <email>robert.zeiser@uniklinik-freiburg.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Petya Apostolova, MD</last_name>
    <phone>076127034010</phone>
    <email>petya.apostolova@uniklinik-freiburg.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical Center University of Freiburg</name>
      <address>
        <city>Freiburg</city>
        <state>Baden-WÃ¼rttemberg</state>
        <zip>79106</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Zeiser, Prof. Dr.</last_name>
      <phone>+49761270</phone>
      <phone_ext>34580</phone_ext>
      <email>robert.zeiser@uniklinik-freiburg.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 16, 2020</study_first_submitted>
  <study_first_submitted_qc>September 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 22, 2020</study_first_posted>
  <last_update_submitted>September 16, 2020</last_update_submitted>
  <last_update_submitted_qc>September 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Freiburg</investigator_affiliation>
    <investigator_full_name>Robert Zeiser</investigator_full_name>
    <investigator_title>Director of the Division of Tumor Immunology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Graft vs Host Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

